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Although women no longer need to agonise if they
cannot remember up to 34 steps of a systematic breast
self examination procedure, or if they forget to do it at
“the right time,” the importance of women continuing
to be “breast aware” and reporting any unusual
changes in their breasts to their general practitioner
promptly cannot be overemphasised.11 This could lead
to a reduced delay in the presentation of any
symptoms discovered by women themselves.12
In the meantime, those of us who have battled
against the breast self examination lobby since 1991
can at last say, in the words of the editorial accompany›
ing the publication of the Shanghai trial, that routinely
teaching and doing breast self examination is dead.13
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Using clinical databases in practice
Individualised prediction of survival for patients with cancer may be possible
In the past decade clinical databases have becomeincreasingly widely used in all industrialisedcountries. This has been accompanied by
enhancements in their quality as a result of greater
understanding of the requirements for scientific
rigour and the availability of technology that can
automate processes such as validity checking. Mean›
while recognition has been growing of the uses to
which high quality clinical databases can be put—
evaluative research, clinical audit, and managing serv›
ices.1 A further but less widely recognised application
is that of helping patients, together with their
practitioners, to make informed decisions about their
clinical management.
An example of such an application is the use of a
breast cancer database in Finland (p 29).2 The Finprog
study uses data on about 2000 women followed up for
10 years to enable an individualised prediction of sur›
vival for a new patient by matching her disease profile
to that of many previous patients with breast cancer
whose outcome is known. The patient and her
practitioner can obtain a survival curve for the entire
available follow up period, not simply an estimate for a
single point in time. Such a system could be applied to
any clinical database that includes accurate infor›
mation on those characteristics of patients that affect
clinical outcome.
Such a development could make a major contribu›
tion to the promotion of patient centred care and help
make meaningful shared decision making a reality.3
The need for such decision support was recognised by
the inquiry into paediatric cardiac surgery in Bristol,
which noted the failure of staff to provide parents with
accurate prognostic information.4 This was not because
the information was withheld but because it wasn’t
available.
The Finprog study illustrates the potential value of
such an approach, but it also highlights three
challenges that lie ahead. Patients and practitioners
are going to require information that is up to date and
reflects local clinical services. At present, users of the
Finprog study obtain information on the outcomes for
a cohort of women diagnosed and treated 10 years
ago. But clinical care has moved on. With ongoing
recruitment, databases would be able to provide more
up to date information (at least for short term
outcomes) reflecting current treatment outcomes. The
second enhancement needed is the ability to provide
data on the outcomes achieved by the healthcare pro›
viders a patient is attending, although inevitably the
relatively small volume of patients treated in any one
setting will limit the statistical confidence of any
estimation of prognosis. The third challenge will be to
show that this approach not only promotes patients’
participation in making decisions but also leads to
health benefits.5 6
The potential scope for using high quality clinical
databases in this way is rapidly expanding with the
growth in the availability of such databases. To encour›
age their use and enhance their quality, a web based
directory of clinical databases (www.docdat.org) has
recently been developed.7 This directory is restricted to
the United Kingdom, but similar websites could be cre›
ated in other countries. When complete the directory
will provide a description of all multicentre clinical
databases that exist in the country and an independent
assessment of the extent and quality of the data
collected. The growing availability of software such as
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that developed in Finland is an exciting step forward in
promoting the use of databases to inform and support
clinical decisions that practitioners and patients face
every day.
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Reporting diagnostic tests
Complying with STARD is likely to improve the quality of reporting
As a clinician, I need high quality evidence aboutthe usefulness, precision, and accuracy ofdiagnostic tests, and I need it now. Such
evidence is rare even for the clinical examination, the
most critical component of the diagnostic process.1 2
The situation is getting worse with the exponential
increase of diagnostic tests, most of which have never
been evaluated properly and can mislead the diagnos›
tic process. Although rigorous methodological stand›
ards in research about diagnostic tests have been
applied more rigorously in the past decade, their
reporting and methodological quality remain
inadequate.2–5 Against this background, the proposal in
this issue from the authors of Standards for Reporting
of Diagnostic Accuracy (STARD) for reporting
diagnostic research should be applauded (p 41).3
There is a precedent for a favourable effect of such
standards in the reporting of randomised trials. Since
the development of the Consolidated Standards of
Reporting Trials (CONSORT)6 and their adoption by
the International Committee of Medical Journal
Editors, the Council of Science Editors, and the World
Association of Medical Editors, the reporting of
randomised trials has improved. Although some of this
may be due to a growing sophistication among trialists
in general, the quality of reports in journals that
promoted CONSORT (BMJ, JAMA, and Lancet) showed
greater improvement than in a journal that did not
advocate its use (New England Journal of Medicine).7
Similarly, although Devereaux and colleagues found
that six of 11 methodological factors outlined in the
CONSORT statement were still reported less than 50%
of the time in 105 recently reported randomised trials
published in 29 journals,8 journals that promoted the
CONSORT statement did better than those that did
not. Although these are encouraging results, referees
and editors of journals need to do a better job in
ensuring that their authors implement the CONSORT
recommendations.
Given that precedent, the STARD criteria, if
applied by investigators and required by editors, may
lead to more high quality evidence about diagnostic
tests. But if this evidence is to be used by busy clinicians,
it must be available quickly and in an easily
understandable form. The promise of the “more
informative abstract” has to be fulfilled by authors and
journals.9 The STARD methodological criteria provide
the basis for more informative abstracts to accompany
diagnostic articles.
Will the publication and recognition of the STARD
statement have a favourable impact on our clinical
practice? Although I agree with the authors of STARD
that complete and informative reporting about
diagnostic tests can only lead to better health care, I am
confident that they would agree that the mere
introduction of STARD is unlikely significantly to
improve the quality and reporting of diagnostic
research. Just as with the CONSORT statement, more
intensive efforts to apply the guidelines will have to be
made by those who develop diagnostic tests, fund and
execute the studies that determine their clinical useful›
ness, and report and disseminate their results. This will
not happen without substantial increases in the
support of diagnostic research and in the translation
and presentation of its results to the front lines of clini›
cal care. Alliance between high quality diagnostic stud›
ies that observe the STARD recommendations and
programmes of systematic reviews of diagnostic
studies such as the one initiated by Matthias Egger and
Daniel Pewsner are welcome. Egger and Pewsner have
created the Bayes Library of Diagnostic Studies and
Reviews, an international consortium conducting
rigorous systematic reviews of studies of diagnostic
accuracy. The alliance should provide journal editors
and translational services with the raw materials that
could give high quality evidence about the usefulness,
precision, and accuracy of diagnostic tests to clinicians,
and give it to them now.
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